Micro Emerging Active

ImmunityBio's ANKTIVA approved in Macau

New narrative with limited coverage — still forming.

Score

0.2

Velocity

▲ 0.0

Articles

Sources

Top Movers

Ticker	Sector	Change
BCG	Financial Services	-17.2%
IBRX	Healthcare	+5.3%

Apr 13, 2026

ImmunityBio, Inc. (IBRX) Posts Strong Preliminary Q1 Sales on ANKTIVA Momentum Bullish

Apr 02, 2026

ImmunityBio (IBRX) Rallies 15% as Firm Raises $100M For Global Expansion Bullish

Mar 25, 2026

ImmunityBio Inc. (IBRX) Announces Approval for ANKTIVA® in Macau SAR, China Neutral

Ticker	Sector	Change
BCG	Financial Services	-17.2%
IBRX	Healthcare	+5.3%

First SeenMar 25, 2026

Last UpdatedMar 25, 2026